Systemic Lupus Erythematosus Flashcards
0
Q
Pathophysiology of SLE
A
- Autoantibodies agains normal body components, results from hyperactivity of B cells (humoral immune response) and because of disordered T cell function (cellular immune response).
- Autoantibodies react with an antigen to form immune complexes, which are then deposited in the connective tissue of blood vessels, lymphatic vessels, & other tissues -> inflammatory response-> inflammation-> local tissue damage.
Kidneys, musculoskeletal system, brain, heart, spleen, lungs, GI tract, skin, and peritoneum.
1
Q
Systemic Lupus Erythematosus
A
- Chronic, inflammatory, connective tissue disease of unknown origin that affects almost all body systems.
- Characterized by remissions and exacerbations
- Majority of cases diagnosed during teenage and early adult years.
- Most characteristic autoantibodies produced against Nucleic acids (DNA), histones etc.
2
Q
Etiology of SLE:
A
- Genetic- certain human leukocyte antigen genes
- environmental- viruses, bacterial agents, chemical drugs, UV light
- hormonal factors- sex hormones, women have reduced levels of androgens. Estrogens have been shown to enhance antibody responses & have an adverse effect in clients with SLE
3
Q
Risk Factors for SLE
A
- Women 9:1 with men
- Women of childbearing age
- More common in AA, Hispanics, Asians than in Caucasians
- Drugs Induced- Procainamide, hydralazine, isoniazid- usually resolve when med is discontinued.
4
Q
3 major classifications of SLE
A
- Systemic lupus
- Drug induced lupus
- discoid lupus
5
Q
Systemic Lupus
A
- Involves one or more of the following systems: Cardiovascular, central nervous, Hematological, kidneys, lungs, and musculoskeletal.
- Renal manifestations- proteinuria, cellular casts, nephrotic syndrome.
- hematologic- anemia, leukopenia, thrombocytopenia
- Cardiovascular- pericarditis, vasculitis, Raynaud’s phenomenon
- CNS- transient nervous system involvement- decline in intellect, memory loss, disorientation, psychosis, seizures, depression, and stroke, conjunctivitis, photophobia, and transient blindness- renal vasculitis
- GI- anorexia, nausea, abd pain, diarrhea
- Liver may be enlarged.
6
Q
Drug Induced Lupus
A
- associated with antineoplastic drugs, isoniazid (INH), hydralazine (Apresoline), and others.
- Symptoms generally subside after drugs are discontinued.
7
Q
Discoid Lupus
A
- Limited to the skin- characteristic red butterfly rash across the cheeks and bridge of the nose.
- Photosensitive- diffuse, maculopapular rash on skin exposed to the sun
- discoid lesions- raised, scaly, circular lesions w/erythematous rim
- hives, Alopecia- hair usually grows back
8
Q
Leading cause of Death in SLE
A
- with active disease there is an increased risk for infections which are often opportunistic and severe
- Pneumonia and Septicemia are the leading causes of death, followed by effects of renal or CNS involvement
9
Q
Manifestations of SLE similar to RA
A
- Early s/s mimic those of RA- fever, loss of appetite, malaise, and weight loss, and musculoskeletal manifestations- multiple arthralgias and symmetric polyarthritis.
- 90% have joint symptoms, synovitis may be present, but is RARELY deforming.
10
Q
Common manifestations of SLE
A
- Painful or swollen joints and muscle pain
- Unexplained fever
- Red rash, especially on the face (Late Stage)
- Unusual loss of hair
- Pale, cyanotic fingers and toes
- Sensitivity to the sun
- edema in legs and around eyes
- Ulcers in the mouth
- Enlarged glands
- Extreme fatigue
11
Q
Raynaud’s Phenomenon
A
Raynaud phenomenon manifests as recurrent vasospasm of the fingers and toes and usually occurs in response to stress or cold exposure. Resulting in discoloration of the fingers, toes, and occasionally other areas.
Cold hands, bluish pigmentation..
12
Q
Conception and SLE
A
- Women who conceieve while in remission appear to have little risk for adverse outcomes.
- Increased risk for spontaneous abortion, still birth, prematurity, and intrauterine growth retardation. Infants may have characteristic skin rash which usually disappears by 12 months.
- Increased risk for congenital heart block- no treatment exists
13
Q
Diagnostic Tests:
A
- Anti-DNA antibody testing- rarely found in any other disorder
- Erythrocyte sedimentation rate
- Serum complement levels- decreased if used up by development of antigen-antibody complexes
- CBC
- Urinalysis- proteinuria, hematuria, blood cell casts
- Kidney biopsy
14
Q
Pharmacologic Therapies:
A
- Aspirin & NSAIDs - anti platelet helps prevent thrombosis, but may cause liver toxicity and hepatitis
- Antimalarial drugs- skin & arthritic manifestations
- corticosteroid- severe life threatening